West Pharmaceutical Services Inc reports results for the quarter ended June 30 - Earnings Summary

West Pharmaceutical Services

23/07/2026 14:31

West Pharmaceutical Services Inc WST.N reported quarterly adjusted earnings of $2.37​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $1.84.  The mean expectation of thirteen analysts for the quarter was for earnings of $2.08 per share. Wall Street expected results to range from $2.05  to $2.10 per share.
Revenue rose 13.8% to $872.30 million from a year ago; analysts expected $838.59 million. 
West Pharmaceutical Services Inc's reported EPS for the quarter was $2.15​.
The company reported quarterly net income of $154 million.
West Pharmaceutical Services Inc shares had fallen by 0.2% this quarter and gained 30.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 1.2% in the last three months.​ 
In the last 30 days, there have been no negative revisions of earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 18 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for West Pharmaceutical Services Inc is $375.00, about 4.4% above its last closing price of $358.41
This summary was machine generated from LSEG data July 23 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
2.08
2.37
Beat
Mar. 31 2026 
1.68
2.13
Beat
Dec. 31 2025 
1.83
2.04
Beat
Sep. 30 2025 
1.68
1.96
Beat